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The 1st EORTC Cancer Survivorship Summit held 30-31 January 2014 in Brussels brought together health care providers,
pharmaceutical industry representatives, bankers and insurers, policy makers, as well as clinicians, researchers and patients
and patient advocacy groups to discuss the specific needs of cancer survivors. This summit stressed the urgent need to address
treatment related morbidity and mortality due to late effects, generally viewed as the domain of medical professionals, as well
as the wide variety of societally significant issues related to survivorship such as jobs, life insurance, mortgages, and normal
re-integration into society with or after cancer.
Targeted sessions held prior to the summit focused on second malignancies, cardiovascular disease, infertility and sexuality,
cognitive dysfunction, and psychosocial impact, e.g. pain, fatigue, work and educational problems. Discussions regarding these
research topics and additional late effects, intervention plans, life beyond cancer, and research issues were introduced to a
broader public. The aim was to structure research lines in better interaction with the patients, health caregivers, insurers,
financial and political people and constructing new collaborations and funding possibilities for this part of cancer care.
This special issue presents detailed information on the topics presented at the Summit in an effort to stimulate action in
these important areas. We think that you will agree that these articles truly set the stage for cancer survivorship efforts in
Europe.
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